JENNIFER SIBIGA: Open Payments
NPI 1952354003 · CAPE MAY CH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 45 payments from 14 companies in 2025. Trend: 2023 $567 · 2024 $810 · 2025 $894
Food & beverage: $794Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $271 |
| Lilly USA, LLC | 3 | $154 |
| Janssen Biotech, Inc. | 4 | $150 |
| Regeneron Healthcare Solutions, Inc. | 4 | $80 |
| LEO Pharma Inc. | 3 | $51 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $34 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $30 |
| GENZYME CORPORATION | 1 | $26 |
| Amgen Inc. | 1 | $18 |
| Galderma Laboratories, L.P. | 1 | $18 |
Products named: TREMFYA, EBGLYSS, SKYRIZI, VRAYLAR, DUPIXENT, ADBRY, Otezla, NEMLUVIO.
Industry payments across NJ — which companies pay providers there.
